Hero MotoCorp to roll out slew of new products in Q2
is gearing up for a series of product launches this quarter as part of a broader strategy to strengthen its position in the domestic and international markets.
The country's largest two-wheeler manufacturer has lined up new offerings across electric vehicles, internal combustion engine motorcycles, and its premium Harley-Davidson portfolio. These launches are aligned with Hero's renewed focus on expanding its international business footprint.
ETAuto
had earlier reported that Hero lost its top spot in retail sales in July to Honda Motorcycle & Scooter India. The upcoming launches are expected to serve as a counter to this growing threat.
The top management confirmed at the company's Q1 FY26 earnings call that the new models were being developed keeping specific global market requirements in mind. 'We are now making products specifically suited to these global markets,' it added.
In the ICE segment, the company plans multiple motorcycle launches in the 125cc category during the current quarter, aimed at strengthening its position in one of the most competitive segments.
As for EVs, Hero will expand the Vida range based on evolving consumer needs. 'There will be more offerings in this space as we build consumer requirements into the product portfolio,' said Kausalya Nandakumar, Chief Business Officer, Emerging Mobility.
Hero will also roll out its second motorcycle developed under its partnership with Harley-Davidson in Q2, based on the 440cc platform. 'One will be launched very soon... and going forward there are a couple of exciting products which will come in 2026,' said Vikram Kasbekar, CEO, Hero MotoCorp.
Global ambitions
The company is targeting 10-12 international markets with models tailored to regional demand. 'We would like to have 10 per cent of our revenue and volumes coming through from the global business. So we are quite aggressive as far as the global business is concerned,' said Vivekanand, Chief Financial Officer.
The company remains optimistic despite supply chain and geopolitical challenges with the management indicating that production plans remain unaffected in the near term.
Rare earth availability is a concern across the auto industry since it affect production of key components in EV motors and sensors (engine speed, wheel speed, bank angle sensors). However, Hero MotoCorp has this shortage covered for both ICE and EV production for this quarter, said the management.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
3 hours ago
- Mint
Top three stocks to buy today—recommended by Ankush Bajaj for 8 August
Stock market today: Frontline indices eked out marginal gains on Thursday, 7 August, supported by late-session buying, even as investor sentiment remained fragile amid mounting concerns over Trump's tariffs and their potential economic impact. The Sensex closed 79 points, or 0.10%, higher at 80,623.26, while the Nifty 50 ended at 24,596.15, up 22 points, or 0.09%. Among broader indices, the BSE Midcap rose 0.30%, while the BSE Smallcap slipped 0.18%. Top 3 Stock Picks by Ankush Bajaj – 8 August Why it's recommended:Hero MotoCorp is showing strong bullish momentum. The daily RSI is at 66, reflecting sustained buying interest. MACD is sharply positive at 55, and ADX at 16 indicates a developing trend. On the daily chart, the stock has broken out of arectangle consolidation pattern, a classic continuation setup that supports the current upward move. The combination of momentum indicators and pattern breakout suggests potential for further upside toward ₹4,750. Key metrics: Breakout zone: Rectangle breakout Pattern: Continuation pattern confirming trend resumption MACD: Positive at 55 RSI: Daily RSI at 66, indicating bullish strength ADX: At 16, suggesting trend development Technical analysis: Breakout confirmation supports upside towards ₹4,750 Risk factors: A close below ₹4,618 would invalidate the breakout and trigger caution. Buy at: ₹4,660 Target price: ₹4,750 Stop loss: ₹4,618 Why it's recommended:Fortis Healthcare is exhibiting strong bullish momentum. The daily RSI is elevated at 72, MACD is firmly positive at 24, and ADX at 38 signals a well-established trend. On the 15-minute chart, the stock has formed adouble bottom pattern, a bullish reversal setup that complements the ongoing momentum. These technical cues collectively suggest a continuation of the uptrend towards ₹909. Key metrics: Breakout zone: Double bottom breakout (15-min chart) Pattern: Reversal pattern supporting trend continuation MACD: Positive at 24 RSI: Daily RSI at 72, indicating strong buying ADX: At 38, confirming trend strength Technical analysis: Lower timeframe breakout and strong momentum indicate potential move to ₹909 Risk factors: A close below ₹868 would invalidate the bullish structure. Buy at: ₹884 Target price: ₹909 Stop loss: ₹868 Why it's recommended:Delhivery is demonstrating strong bullish momentum, marked by anew lifetime high on the charts. The daily RSI stands at 69, MACD is positive at 16, and ADX at 41 confirms robust trend strength. The breakout to a new high is a significant bullish signal, often attracting momentum-based buying. These technical factors collectively point toward an upside target of ₹500. Key metrics: Breakout zone: New lifetime high Pattern: Momentum breakout MACD: Positive at 16 RSI: Daily RSI at 69, reflecting strong bullish sentiment ADX: At 41, indicating a strong trend Technical analysis: New high breakout with strong momentum suggests move to ₹500 Risk factors: A close below ₹450 would negate the bullish setup. Buy at: ₹465.75 Target price: ₹500 Stop loss: ₹450 Market Wrap | 7 August The Nifty 50 edged up 21.95 points, or 0.09%, to close at 24,596.15 on Thursday, while the BSE Sensex rose 79.27 points, or 0.10%, ending the day at 80,623.26. The Bank Nifty also joined the rebound, climbing 110 points, or 0.20%, to finish at 55,521.15, reflecting a gradual recovery in financials. Sectoral trends remained mixed and largely subdued. Defensive pockets like PSEs fell 0.45%, the Infrastructure index slipped 0.25%, and the Energy sector eased 0.20%, pointing to ongoing profit booking. On the other hand, Pharma gained 0.75%, Healthcare rose 0.61%, and PSU Banks edged up 0.29%, signalling selective value buying in safer or underperforming segments. Among individual stocks, Hero MotoCorp stood out with a strong 4.15% rally, driven by institutional interest. Tech Mahindra added 1.58%, while JSW Steel rose 1.16%, supported by selective accumulation in quality large-caps. Nifty Technical Analysis | Daily & Hourly On 7 August, the Nifty closed marginally higher at 24,596.15, up 21.95 points, or 0.09%, indicating a modest intraday recovery. However, this minor uptick does little to alter the broader corrective trend that has dominated recent sessions. The index continues to face strong resistance at key levels, and the overall structure remains weak and susceptible to further downside pressure. Technically, the Nifty is still trading below its key short-term moving averages. Both the 20-day SMA and the 40-day EMA are placed at 24,911, and the index has so far failed to reclaim these levels. Even on the intraday charts, the Nifty is trading below the 20-hour SMA at 24,626 and the 40-hour EMA at 24,566, highlighting persistent selling pressure on any minor upticks. As long as the index remains below these averages, the directional bias remains neutral to negative. Momentum indicators continue to signal weakness. The daily RSI has slipped to 39, indicating a lack of bullish momentum, while the MACD remains deep in negative territory at -141, with no signs of a bullish crossover. On the hourly chart, there are minor signs of improvement: the hourly RSI has ticked up to 53, and the MACD has inched higher to -46, but these are not convincing enough to suggest a trend reversal. Overall, the momentum setup supports the view that any current bounce is likely corrective and not a signal of a sustainable turnaround. From a derivatives perspective, the broader trend still leans bearish. The total Call open interest (OI) stands at 20.22 crore, significantly higher than the Put OI of 16.44 crore, keeping the put-call ratio (PCR) suppressed at 0.81. However, the change in OI tells a slightly different story — while Call OI rose by 43.53 lakh, Put OI jumped by 4.50 crore, resulting in a net bullish OI change of 4.06 crore contracts. This could indicate that some traders are beginning to hedge for a potential bounce or are covering shorts. Still, the heavier Call OI continues to cap the upside. Strike-specific positioning also provides important cues. The 24,600 strike holds both the highest Call OI and the highest Call additions, confirming it as a strong resistance zone. On the other hand, the 24,550 strike has emerged as the maximum Put OI and saw the most Put additions, suggesting an effort to defend this support level. But with the Nifty closing only slightly above it, any weakness from here could jeopardize this support and expose the index to further losses. In summary, Nifty remains in a fragile and corrective phase with no clear signs of a sustainable recovery yet. The inability to reclaim short-term moving averages and the overall bearish structure in the options data continue to weigh on sentiment. The 24,911–25,000 zone remains a key barrier — only a decisive close above this region could tilt the trend back toward bullish. Until that happens, any move higher should be seen as a temporary pullback within a larger downtrend. Immediate support lies at 24,550–24,450, and a breakdown below this zone could lead to a deeper correction towards 24,000, where an unfilled gap still remains. For traders, the strategy remains to adopt a sell-on-rise approach, particularly near resistance levels like 24,600–24,700. Avoid initiating aggressive long positions unless the Nifty manages to close above 25,000 with strength and volume. The current environment remains cautious and tactical, with traders needing to monitor key levels closely for either signs of bottom formation or renewed breakdown. Ankush Bajaj is a Sebi-registered research analyst. His registration number is INH000010441. Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.
Time of India
3 hours ago
- Time of India
LIC profit grows 5% despite lower equity gains in a volatile Q1
Mumbai: Life Insurance Corp (LIC), the second largest government asset by market value, reported a 5% increase in its net profit to ₹10,986 crore, as moderating capital gains from equity sales through a volatile June quarter offset a robust core operating performance. Fiscal Q1 net trailed Bloomberg estimates of ₹11,100 crore. "The slowdown in net profit growth is mainly due to lower capital gains from equity markets. However, the core insurance operating profit remains strong," LIC MD & CEO R Doraiswamy said in a post-earnings call. LIC did not offer growth guidance for FY26 but said it is aiming for double-digit profit expansion for full year. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program "That is the level we consider respectable and we are targeting that," Doraiswamy added. The yield on policyholders' funds (excluding unrealized gains) declined to 8.45% in Q1 FY26 from 8.54% in Q1 FY25. LIC booked 15% growth in equity market profits on quarter. Its total equity market sales were upwards of ₹50,000 crore. The value of new business (VNB) rose 20.75% to ₹1,944 crore, while the VNB margin went up by 150 basis points to 15.4%. Doraiswamy attributed the margin boost to product changes and other initiatives. "Our margin improved to 15.4% in Q1, up from 13.9%, primarily due to a rise in non-par business, which now stands at 30.34%," said Doraiswamy. "Several interventions contributed including product modifications, changes in margin structures, and revisions in minimum ticket sizes and premiums to improve persistence." Annualised premium equivalent (APE) rose 9.45% year-on-year to ₹12,652 crore. The share of non-participating (non-par) APE within individual business jumped to 30.34%, up from 23.94% in the same period last year, as the insurer continued to boost non-par business post-IPO. Live Events "Since the IPO, the focus has been on scaling up non-par," said LIC Managing Director Dinesh Pant. "Non-par share has climbed from just 7% at the time of listing to 30% now." The company has not introduced new participating products since the IPO but now plans to develop the segment with an expected growth rate of 5-10%, he said. Pant said that while LIC is operating within a 40-60% non-par to non-par directional mix, this will continue to evolve based on market conditions and profitability. Persistency ratios, a key metric of policy renewals, dropped to 75.63% for the 13th month against 78.23% and rose to 63.85% from 61.62% for the 61st month on a premium basis. Short-term persistence saw some decline, largely driven by lapses in lower ticket-size policies sold under the earlier regulatory regime. "Many of these are revived later," an LIC executive said. On health insurance front, LIC said it is still exploring options for its proposed health insurance joint venture. "We are evaluating multiple possibilities and awaiting clarity on changes in the insurance Act and other regulatory developments," said Doraiswamy. ETMarkets WhatsApp channel )
&w=3840&q=100)
Business Standard
9 hours ago
- Business Standard
Govt body NRDC suggests mandatory policy framework for zero emissions
ZEV credits will be calculated based on the difference between the ZEV-mandated requirements and the number of vehicles sold by the manufacturer Surajeet Das Gupta Listen to This Article An organisation under the Ministry of Science and Technology has recommended a portion of a vehicle manufacturer's annual sales, to be set each year, should be zero-emission vehicles (ZEVs). The National Research Defence Council (NRDC), a body which is under the Ministry of Science and Technology and which, with the Ministry of Heavy Industries, works on environmental solutions, in its report released on Wednesday, has made the proposal, which is in line with the government considering a shift in its policy framework for increasing electric-vehicle (EV) penetration by moving from incentive-based support and subsidies under Faster Adoption and Manufacturing Electric
